By Doctor David Goodman Jr

Book Chapters

Goodman-Meza D, 2025, 'Treating Fentanyl Addiction', in Fentanyl from the Labs to the Streets, pp. 80 - 95, http://dx.doi.org/10.4324/9781003631873-6

Journal articles

Bradford W; Dye D; Jensen R; Bratches R; Marshall S; Eaton E; Figgatt M; Taylor W; Walter LA; Goodman-Meza D; Kertesz S; Scott KS, 2026, 'Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility study', Harm Reduction Journal, 23, http://dx.doi.org/10.1186/s12954-026-01401-5

Nyein PP; Haskelberg H; Martinello M; Lowe M; Goodman-Meza D; Avihingsanon A; Kelleher AD; Rodgers A; Schutte AE; Nnakelu EC; Byakwaga H; Trevillyan J; Losso M; Kumarasamy N; Azwa RISR; Kaplan R; Clifton B; Arnott C; Dharan NJ; Petoumenos K; Matthews GV, 2026, 'Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk', Trials, 27, http://dx.doi.org/10.1186/s13063-026-09723-2

Schmidt RA; Perez-Brumer A; Davidson P; Shoptaw S; El-Bassel N; Andrew P; Harris J; Nieto O; Bornstein S; Redd R; Yeager J; Goodman-Meza D; Hasson AL; Seigel M; Denis C; El-Krab R; Smith LR, 2026, 'Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70198

McKetin R; Shoptaw S; Saunders L; Nguyen L; Clare PJ; Dore GJ; Turner A; Dean OM; Kelly PJ; Arunogiri S; Koeijers J; Degan TJ; Degenhardt L; Farrell M; Goodman-Meza D; Sinclair B; Reid D; Cordaro F; Hill H; Lundin R; Hayllar J; Christmass M; Liaw W; Liu D; Woods A; Brewerton B; Holyoak E; Wu BTF; Maher H; O'Dea N; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Kiden G; Romeo V; Kyaw KWY; Byrne M; Colledge-Frisby S; Zahra E; Berk M, 2026, 'Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial', JAMA Psychiatry, 83, pp. 581 - 589, http://dx.doi.org/10.1001/jamapsychiatry.2026.0159

Funnell AJ; Petousis P; Harel-Canada F; Romero R; Bui AAT; Koncsol A; Chaturvedi H; Shover C; Goodman-Meza D, 2026, 'Improving drug identification in overdose death surveillance by using clinical natural language processing models', Journal of Forensic Sciences, 71, pp. 1329 - 1337, http://dx.doi.org/10.1111/1556-4029.70281

Goodman-Meza D; Martinello M; Masters J; Russell D; Jacka B; Matthews GV; Dore GJ, 2026, 'Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian Hospital', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70169

El-Bassel N; Shoptaw S; Skalland T; Hanscom B; Clarke W; Marzinke MA; Fogel JM; Richardson P; Choudhury RP; Denis C; Goodman-Meza D; Kuo I; Lake JE; Morrison EAB; Richards AM; Harris-Wisecarver J; Cummings M; Chandler R; Andrew P, 2026, 'Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs', JAMA Network Open, 9, http://dx.doi.org/10.1001/jamanetworkopen.2025.55882

García de Loera A; Angulo Corral L; González Nieto P; Arredondo Sánchez Lira J; Goodman-Meza D, 2026, 'TRIPLE ESTIGMA', Revista Brasileira de Segurança Pública, 20, pp. 220 - 247, http://dx.doi.org/10.31060/rbsp.2026.v20.n1.2122

Friedman JR; Romero R; Funnell A; Goodman-Meza D; Shover CL, 2026, 'What does 'polysubstance' really mean? Comparing drug-involved deaths in CDC records vs. detailed medical examiner data from Los Angeles', International Journal of Drug Policy, 148, http://dx.doi.org/10.1016/j.drugpo.2025.105129

Tsuyuki K; El-Krab R; Shoptaw S; El-Bassel N; Lake JE; Magnus M; Kuo I; Goodman-Meza D; Denis C; Nieto O; Franks J; Villareal YR; Smith P; Bornstein S; Andrew P; Harris-Wisecarver J; Choudhury RP; Perez-Brumer A; Davidson P; Smith LR, 2026, '“Delivering high-quality care in this setting requires a lot of resources”: HPTN 094 Implementation Lessons from Delivering Integrated HIV and MOUD Care Through Mobile Units In Local Neighborhoods', Journal of Acquired Immune Deficiency Syndromes 1999, http://dx.doi.org/10.1097/QAI.0000000000003947

El-Bassel N; Shoptaw S; Hanscom B; Skalland T; Hasson A; Denis C; Goodman-Meza D; Kuo I; Lake JE; Redd R; Richards AM; Paul Choudhury R; Cummings M; Harris-Wisecarver J; Fogel J; Richardson P; Chandler R; Smith LR; Metzger D; Andrew P, 2026, 'The HPTN 094 Peer Navigation Model: Integration of Substance Use Treatment and HIV Prevention and Care for People Who Inject Drugs', Journal of Addiction Medicine, http://dx.doi.org/10.1097/ADM.0000000000001759

Bejarano-Romero R; Sánchez-Lira JA; Rafful C; Pitpitan EV; Esparza-Méndez LE; Poimboeuf M; Shover CL; Goodman-Meza D, 2025, 'Exploring potential underestimates in fatal overdose mortality across major metropolitan areas in Mexico between 2005 and 2019', BMC Public Health, 25, http://dx.doi.org/10.1186/s12889-025-25249-9

Harel-Canada F; Salimian A; Moghanian B; Clingan S; Nguyen A; Avra T; Poimboeuf M; Romero R; Funnell A; Petousis P; Shin M; Peng N; Shover CL; Goodman-Meza D, 2025, 'Enhancing substance use detection in clinical notes with large language models', Drug and Alcohol Dependence, 276, http://dx.doi.org/10.1016/j.drugalcdep.2025.112888

Shover CL; Koncsol AJ; Godvin ME; Goodman-Meza D; Pardo B; Poimboeuf M; Molina CA; Romero R; Feng J; Friedman JR, 2025, 'High variation in purity of consumer-level illicit fentanyl samples in Los Angeles, September 2023–April 2025', International Journal of Drug Policy, 145, http://dx.doi.org/10.1016/j.drugpo.2025.104977

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs', Clinical Microbiology Reviews, 38, http://dx.doi.org/10.1128/cmr.00162-23

Shover CL; Friedman JR; Romero R; Jimenez S; Beltran J; Garcia C; Goodman-Meza D, 2025, 'Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States', International Journal of Drug Policy, 141, http://dx.doi.org/10.1016/j.drugpo.2024.104397

Benrubi L; Sato T; Westgard LK; Zollo-Venecek K; Socrates B; Sweigart B; Ridgway JP; Suzuki J; Morales Y; Goodman-Meza D; Wurcel AG, 2025, 'Sensitivity and Specificity of Natural Language Processing Systems for Identification of Hospitalized People Who Use Drugs', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf370

Avra T; Nelson A; Friedman J; Limbach W; Sarkisian M; Nesley T; Chu T; Truman K; Moghanian B; Yazditabar J; Ahluwalia T; Shover C; Goodman-Meza D, 2025, 'Substance Use Disorder and Harm Reduction Curriculum in United States and Canadian Undergraduate Medical Education: An Online Survey', Substance Use and Addiction Journal, 46, pp. 704 - 710, http://dx.doi.org/10.1177/29767342251313595

Goodman-Meza D; Weiss RE; Poimboeuf ML; Feng J; Vijayan T; Martinello M; Matthews GV; Dore GJ, 2025, 'Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.11641

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, pp. ofaf257, http://dx.doi.org/10.1093/ofid/ofaf257

Yousefzadeh M; Goodman-Meza D; Allyn PR, 2025, 'P-1098. Clinical outcomes in four patients with refractory Coccidioidal meningitis treated with olorofim', Open Forum Infectious Diseases, 12, pp. ofae631.1286, http://dx.doi.org/10.1093/ofid/ofae631.1286

Wulf DA; Hazlett C; Hill BL; Chiang JN; Goodman-Meza D; Pasaniuc B; Arah OA; Erlandson KM; Montague BT, 2025, 'Safe inference outside of randomized trials: Application of the stability-controlled quasi-experiment to the effects of three COVID-19 therapies', Observational Studies, 11, pp. 301 - 330, http://dx.doi.org/10.1353/obs.2025.a973069

Molina C; Romero R; Sisco E; Friedman J; Goodman-Meza D; Nunez L; Urich T; Jalayer E; Davila S; Snakeoil S; Guerra S; Elizabeth J; Shover C, 2025, 'Evaluating Xylazine Immunoassay Test Strips in Street-Based Samples of Rocks, Powder, Pills, and Tar in Los Angeles, California', Drug and Alcohol Dependence, 267, pp. 111955 - 111955, http://dx.doi.org/10.1016/j.drugalcdep.2024.111955

Smith LR; Perez-Brumer A; Nicholls M; Harris J; Allen Q; Padilla A; Yates A; Samore E; Kennedy R; Kuo I; Lake JE; Denis C; Goodman-Meza D; Davidson P; Shoptaw S; El-Bassel N, 2024, 'A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities', Implementation Science, 19, http://dx.doi.org/10.1186/s13012-024-01363-x

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Goodman-Meza D; Shoptaw S; Hanscom B; Smith LR; Andrew P; Kuo I; Lake JE; Metzger D; Morrison EAB; Cummings M; Fogel JM; Richardson P; Harris J; Heitner J; Stansfield S; El-Bassel N, 2024, 'Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study)', Trials, 25, http://dx.doi.org/10.1186/s13063-023-07899-5

Sundaram G; Sato T; Goodman-Meza D; Haddad M; Thakarar K; Feinberg J; Springer SA; Barton K; Butler N; Eaton EF; Wurcel AG, 2024, 'Perspectives on benefits and risks of creation of an “injection drug use” billing code', Journal of Substance Use and Addiction Treatment, 164, http://dx.doi.org/10.1016/j.josat.2024.209392

Samuels EA; Rosen AD; Speener M; Kaleekal J; Kalmin MM; Goodman-Meza D; Shoptaw S; Clayton S; Lin C; Campbell A; Moulin A; Herring AA, 2024, 'Scaling Emergency Department Opioid Use Disorder Treatment Across California to Reduce Overdose Deaths, 2019–2023', American Journal of Public Health, 114, pp. 874 - 878, http://dx.doi.org/10.2105/AJPH.2024.307710

Lira JAS; Goodman-Meza D, 2024, 'Overdose and COVID-19 in Baja California, Mexico: The Need for New Methodologies for Understanding Local Trends', American Journal of Public Health, 114, pp. 590 - 592, http://dx.doi.org/10.2105/AJPH.2024.307672

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Goodman-Meza D; Goto M; Salimian A; Shoptaw S; Bui AAT; Gordon AJ; Goetz MB, 2024, 'Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject Drugs', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae030

Scialli A; Saab S; Salimian A; Bhattacharya D; Goodman-Meza D, 2024, 'Hepatitis C Treatment Among Primary Care and Specialty Providers: A Single Center Study, 2015 to 2022', Journal of Primary Care and Community Health, 15, http://dx.doi.org/10.1177/21501319241253521

Gonzalez-Nieto P; Salimian A; Arredondo J; Angulo L; García de Loera A; Slim S; Shoptaw S; Cambou MC; Pitpitan EV; Goodman-Meza D, 2023, 'Intersections between syndemic conditions and stages along the continuum of overdose risk among women who inject drugs in Mexicali, Mexico', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00815-9

Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL, 2023, 'Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study', Drug and Alcohol Dependence, 249, http://dx.doi.org/10.1016/j.drugalcdep.2023.110819

Shover CL; Friedman JR; Romero R; Buhr R; Chu B; Tang A; Medina JA; Wisk L; Lucas J; Goodman-Meza D, 2023, 'Longitudinal changes in co-involved drugs, comorbidities, and demographics of methamphetamine-related deaths in Los Angeles County', Journal of Substance Use and Addiction Treatment, 151, http://dx.doi.org/10.1016/j.josat.2023.209101

Strathdee SA; Goodman-Meza D; Rafful CM, 2023, 'Addressing opioid use disorder: Mexico's step backwards', Lancet Regional Health Americas, 23, http://dx.doi.org/10.1016/j.lana.2023.100520

Bejarano Romero R; Arredondo Sánchez-Lira J; Slim Pasaran S; Chávez Rivera A; Angulo Corral L; Salimian A; Romero Vadilllo JJ; Goodman-Meza D, 2023, 'Implementing a decentralized opioid overdose prevention strategy in Mexico, a pending public policy issue', Lancet Regional Health Americas, 23, http://dx.doi.org/10.1016/j.lana.2023.100535

Romero R; Friedman JR; Goodman-Meza D; Shover CL, 2023, 'US drug overdose mortality rose faster among hispanics than non-hispanics from 2010 to 2021', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109859

Edwards GG; Miyashita-Ochoa A; Castillo EG; Goodman-Meza D; Kalofonos I; Landovitz RJ; Leibowitz AA; Pulsipher C; El Sayed E; Shoptaw S; Shover CL; Tabajonda M; Yang YS; Harawa NT, 2023, 'Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine', AIDS and Behavior, 27, pp. 10 - 24, http://dx.doi.org/10.1007/s10461-022-03817-z

Filosa JN; Botello-Mares A; Goodman-Meza D, 2022, 'COVID-19 needs no passport: the interrelationship of the COVID-19 pandemic along the U.S.-Mexico border', BMC Public Health, 22, http://dx.doi.org/10.1186/s12889-022-13513-1

Garrigos ZE; Wingler MJB; Svoronos PA; Vijayvargiya P; Goodman-Meza D; O'Horo JC; Navalkele BD; Cretella D; Frame IJ; Parham J; Lucar J, 2022, 'Increased rates of blood culture contamination during the coronavirus disease 2019 pandemic', Infection Control and Hospital Epidemiology, 43, pp. 1719 - 1721, http://dx.doi.org/10.1017/ice.2021.292

Goodman-Meza D; Tang A; Aryanfar B; Vazquez S; Gordon AJ; Goto M; Goetz MB; Shoptaw S; Bui AAT, 2022, 'Natural Language Processing and Machine Learning to Identify People Who Inject Drugs in Electronic Health Records', Open Forum Infectious Diseases, 9, http://dx.doi.org/10.1093/ofid/ofac471

Goodman-Meza D; Shover CL; Medina JA; Tang AB; Shoptaw S; Bui AAT, 2022, 'Development and Validation of Machine Models Using Natural Language Processing to Classify Substances Involved in Overdose Deaths', JAMA Network Open, 5, pp. e2225593, http://dx.doi.org/10.1001/jamanetworkopen.2022.25593

Goodman-Meza D; Arredondo J; Slim S; Angulo L; Gonzalez-Nieto P; Loera A; Shoptaw S; Cambou MC; Pitpitan EV, 2022, 'Behavior change after fentanyl testing at a safe consumption space for women in Northern Mexico: A pilot study', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103745

Friedman J; Montero F; Bourgois P; Wahbi R; Dye D; Goodman-Meza D; Shover C, 2022, 'Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis', Drug and Alcohol Dependence, 233, http://dx.doi.org/10.1016/j.drugalcdep.2022.109380

Shoptaw S; Li MJ; Javanbakht M; Ragsdale A; Goodman-Meza D; Gorbach PM, 2022, 'Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109320

Goodman-Meza D; Slim S; Angulo L; Gonzalez-Nieto P; Cambou MC; Loera A; Shoptaw S; Arredondo J, 2022, 'Impact of an overdose reversal program in the context of a safe consumption site in Northern Mexico', Drug and Alcohol Dependence Reports, 2, http://dx.doi.org/10.1016/j.dadr.2021.100021

Jolayemi O; Bogart LM; Storholm ED; Goodman-Meza D; Rosenberg-Carlson E; Cohen R; Kao U; Shoptaw S; Landovitz RJ, 2022, 'Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County', Plos One, 17, http://dx.doi.org/10.1371/journal.pone.0262926

Yang B; Fulcher JA; Ahn J; Berro M; Goodman-Meza D; Dhody K; Sacha JB; Naeim A; Yang OO, 2021, 'Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab', Clinical Infectious Diseases, 73, pp. E4082 - E4089, http://dx.doi.org/10.1093/cid/ciaa1583

Back to profile page